APSR2026-709

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-018
P26
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220805-46904-26.11.11.APSR26_Poster_439193.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Keisuke Kasuga * Kyorin University
 Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Ken Shirato - Kyorin University
 Department of Molecular Predictive Medicine and Sport Science, Faculty of Medicine Tokyo Japan
Masaoki Saito - Kyorin University
 Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Jumpei Aso - Kyorin University
 Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Hiroki Nunokawa - Kyorin University Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Mitsuru Sada - Kyorin University Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Keitaro Nakamoto - Kyorin University Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Takeshi Saraya - Kyorin University Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
Haruyuki Ishii - Kyorin University Department of Respiratory Medicine, Faculty of Medicine Tokyo Japan
 
 
 
 
 
 
Presenting Author Details
Keisuke
Kasuga
kkclub_0518@yahoo.co.jp
+819049621287
31-40
Japan
Original Research
Initial antibiotic selection for adult pneumonia: differences between respiratory and non-respiratory physicians
Maximum 25 words
Abstract Content
The JRS Guideline for the Management of Pneumonia in Adults 2024 is widely used in Japan; however, antibiotic selection in clinical practice may differ depending on physician specialty. We aimed to investigate real-world initial antibiotic selection for adult pneumonia using a questionnaire-based survey.
Physicians involved in pneumonia management were asked to select initial antibiotics for three hypothetical cases: (1) mild community-acquired pneumonia suspected to be bacterial, (2) mild atypical pneumonia, (3) moderate aspiration pneumonia without risk factors for resistant organisms. Antibiotic selection was compared between respiratory physicians and non-respiratory physicians.
A total of 103 responses were analyzed (respiratory physicians 66, non-respiratory physicians 37). For mild community-acquired pneumonia, amoxicillin/clavulanate ± amoxicillin was most frequently selected (88.3%). Respiratory fluoroquinolones were selected more often by non-respiratory physicians (7.7% vs 20.6%), although guidelines recommend penicillin-based therapy for bacterial pneumonia. For mild atypical pneumonia, azithromycin was most frequently selected (63.6%), whereas respiratory fluoroquinolones were selected in 26.3% and tetracyclines in only 5%. Among physicians aware of macrolide-resistant Mycoplasma, macrolides were selected less frequently (72% vs 100%) and fluoroquinolones more frequently (35% vs 0%) (Fisher’s exact test, p<0.05). Although tetracyclines are recommended for macrolide-resistant Mycoplasma, their use was limited in clinical practice. For moderate aspiration pneumonia, ampicillin/sulbactam or ceftriaxone was commonly selected by respiratory physicians (98.4% vs 79.4%), whereas piperacillin/tazobactam was selected more frequently by non-respiratory physicians (0% vs 14.7%, Fisher’s exact test p<0.01).
Initial antibiotic selection for adult pneumonia differed according to physician specialty. Non-respiratory physicians tended to select broader-spectrum antibiotics than recommended by guidelines, suggesting the need for further dissemination of guideline-based antimicrobial stewardship.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pneumonia, Antibiotic, Guideline
maximum 3 keywords and no abbreviations, separated by commas
 
274